Science Explorer Back to mapMap
Discussion
Researcher · Bayer (Germany) · Germany

Sven Golfier

Sven Golfier publishes mostly in Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology, on topics such as Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research and HER2/EGFR in Cancer Research.

ORCID 0009-0005-6506-8182 OpenAlex
World rank
#569,638
of 7,710,434 ranked researchers
Rank in Germany
#28,027
of 364,343
Works
120
Citations
1.8k
Citations per work
15.2
h-index
19
i10-index 25Top 23% in Radiology, Nuclear Medicine and Imaging
Sven Golfier

What does Sven Golfier research?

Sven Golfier's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (10%).

Health Sciences: 51 works · 42.3% of their workMedicine: 51 works · 42.3% of their workRadiology, Nuclear Medicine and Imaging: 22 works · 18.3% of their workOncology: 20 works · 16.3% of their workPulmonary and Respiratory Medicine: 9 works · 7.7% of their workLife Sciences: 38 works · 31.7% of their workBiochemistry, Genetics and Molecular Biology: 27 works · 22.1% of their workMolecular Biology: 20 works · 16.3% of their workCell Biology: 7 works · 5.8% of their workImmunology and Microbiology: 12 works · 9.6% of their workImmunology: 12 works · 9.6% of their workEverything else: 31 works · 26.0% of their workTHEIR WORKSven Golfier120works
Life Sciences32%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5142.3%
    1. Biochemistry, Genetics and Molecular Biology2722.1%
    2. Immunology and Microbiology129.6%
  3. Everything else3126.0%
  1. 1Radiology, Nuclear Medicine and Imaging18% of their works
  2. 2Molecular Biology16% of their works
  3. 3Oncology16% of their works
  4. 4Immunology10% of their works
  5. 5Pulmonary and Respiratory Medicine8% of their works
  6. 6Cell Biology6% of their works

Research topics

Which keywords describe Sven Golfier's research?

The keywords of their largest research topics: Cancer, Fc Receptors, Natural Killer Cells, NK Cell Recognition, Targeted Therapy, Therapeutic Antibodies, BAP1 mutations and Breast Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer72 topics
  2. Fc Receptors71 topic
  3. NK Cell Recognition71 topic
  4. Natural Killer Cells71 topic
  5. Targeted Therapy72 topics
  6. Therapeutic Antibodies71 topic
  7. BAP1 mutations51 topic
  8. Breast Cancer51 topic
  9. HER251 topic
  10. Malignant Pleural Mesothelioma51 topic
  11. Hippo Pathway41 topic
  12. PET Imaging41 topic
  13. Radiopharmaceuticals41 topic
  14. YAP/TAZ41 topic
  15. ALK Inhibitors31 topic
  16. EGFR Mutations31 topic
  17. Sphingolipids31 topic
  18. Sphingosine-1-Phosphate31 topic

Where does Sven Golfier work?

Sven Golfier's main affiliation in the publication record is Bayer (Germany), Germany.

How many publications and citations does Sven Golfier have?

OpenAlex counts 120 works and 1,828 citations for Sven Golfier, an h-index of 19, ranking #569,638 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sven Golfier. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.